Advertisement

Topics

Latest "ZymoGentics Incorporated" News Stories

03:03 EDT 20th October 2017 | BioPortfolio

Here are the most relevant search results for "ZymoGentics Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about ZymoGentics Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ZymoGentics Incorporated for you to read. Along with our medical data and news we also list ZymoGentics Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of ZymoGentics Incorporated Companies for you to search.

Showing "ZymoGentics Incorporated" News Articles 1–25 of 41

Wednesday 18th October 2017

Dynavax Initiates Clinical Trial in Non-Small Cell Lung Cancer with a Novel Inhaled TLR9 Agonist in Combination with Anti-PD-1 Therapy

BERKELEY, CA--(Marketwired - October 19, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) announced initiation of dosing in a phase 1B dose escalation clinical trial of its investigational inhaled toll-like receptor 9 (TLR9) agonist, DV281, in patients with non-small cell lung cancer (NSCLC). This multi-center, open label trial is designed to evaluate safety and identify the optimal dose f...


Thursday 5th October 2017

Pharmacovigilance Database E2B(R3) Compliance: A Technical and Practical Perspective

TORONTO, ON--(Marketwired - October 06, 2017) - In a complimentary webinar taking place on Thursday, October 26, 2016 at 11am EDT (4pm BST) industry experts Tom Nichols, Senior Director of Pharmacovigilance at Quanticate and Dr. Marc Zittartz, Chief Quality Officer at Pharmasol will address a major step forward in the pharmaceutical industry from both a technical perspective as well as the day-to...

Wednesday 4th October 2017

Angle PLC: Results of Fundraising

GUILDFORD, SURREY -- (Marketwired) -- 10/05/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY) (AIM:AGL OTCQX:ANPCY) THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR ANY...


Tuesday 3rd October 2017

Advanced Bifurcation Systems Announces Plan for Human Clinical Trials in New Brunswick, Canada

LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company is planning to undertake human cl...

Monday 2nd October 2017

Teleflex Incorporated Completes Acquisition of NeoTract

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies designed to improve the health and quality of people’s lives, announced today the completion of its previously announced acquisition of NeoTract, Inc. On September 5, 2017, the two companies announced a definitive agreement for Teleflex to acquire NeoTract in a ...

Monday 18th September 2017

MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage...

Herbalife Announces Amendment and Extension of Its Tender Offer for Common Shares

Herbalife Ltd. (NYSE: HLF) (“Herbalife”) announced today it is amending its previously announced cash tender offer in order to clarify or expand upon certain disclosures in response to comments from the Securities and Exchange Commission (“SEC”), including providing more detail regarding contingent value rights (each, a “CVR”), which make up a part of...

Wednesday 13th September 2017

Milestone Scientific Announces Children's Hospital of Pittsburgh to use The Wand(R) Computer Assisted Anesthesia System for Pediatric Patients

LIVINGSTON, NJ --(Marketwired - September 14, 2017) - Milestone Scientific Inc. (NYSE American: MLSS) (NYSE MKT: MLSS), a medical company that develops and commercializes a growing portfolio of proprietary injection technologies, today announced that the Children's Hospital of Pittsburgh will now utilize The Wand® computer assisted anesthesia system for its pediatric patients. In addition, The Wa...

Monday 28th August 2017

Study Confirms RenalGuard(R) Efficacy for Dramatically Lowering Risk of Contrast-Induced Acute Kidney Injury

MILFORD, MA--(Marketwired - August 29, 2017) - New clinical research confirms the ability of RenalGuard® to dramatically lower the risk of contrast-induced nephropathy (CIN) compared to the risk predicted by validated Mehran CIN scores for patients with kidney impairment who are exposed to contrast agents as part of cardiac catheterization procedures. Moreover, 58 patients undergoing such procedu...

Herbalife Announces Waiver and Amendment of Condition to Its Tender Offer for Common Shares

Herbalife Ltd. (NYSE: HLF) (“Herbalife” or “Company”) announced today it has waived the share price condition related to its previously announced cash tender offer for its common shares, par value $0.001 per share (“shares”), for an aggregate cash purchase price of up to $600 million and at a per share price not less than $60.00 nor greater than $68.0...

Monday 21st August 2017

Herbalife Announces Self-Tender Offer Seeking to Purchase up to $600 Million of Its Outstanding Common Shares

Herbalife Ltd. (NYSE: HLF) (“Herbalife” or “the Company”) announced today it has commenced a “modified Dutch auction” self-tender offer to purchase for cash up to an aggregate of $600 million of shares of its common stock at a per share price not less than $60.00 nor greater than $68.00. For each share tendered, shareholders will also receive a ...

Sunday 13th August 2017

Amedica Announces Adjournment of Special Meeting of Stockholders

SALT LAKE CITY, UT -- (Marketwired) -- 08/14/17 -- Amedica Corporation (NASDAQ: AMDA), an innovative medical device company that develops and commercializes silicon nitride, announced that the special meeting of stockholders scheduled for today has been adjourned, with the adjournment itself being the only business conducted. The adjournment is to allow for the solicitation of additional votes i...

Tuesday 8th August 2017

Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2017

FRANKLIN, Tenn., Aug. 8, 2017 /PRNewswire/ -- Community Healthcare Trust Incorporated (NYSE: CHCT) (the "Company") today announced results for the three months ended June 30, 2017. The Company reported net income for the first quarter of approximately $0.5 million, or $0.04 per diluted common share. Normalized funds from operations and adjusted funds from operations for the thr...

Mannatech Reports Second Quarter 2017 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2017. Second Quarter Results Second quarter net

Monday 7th August 2017

Microbix Announces Expanded Customer Supply Agreement

TORONTO, ONTARIO -- (Marketwired) -- 08/08/17 -- Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, announces the execution of an agreement to supply an existing long-term customer with an increasing quantity of Microbix' viral antigen products over the next five years, with the parties having the option to extend that term. Sales from the agreement are ex...

Thursday 3rd August 2017

Teleflex Reports Second Quarter 2017 Results

Second Quarter Revenues of $528.6 million, up 11.6% Versus Prior Year Period; up 12.9% on Constant Currency Basis Second Quarter GAAP Diluted EPS of $1.67, up 33.6% Over Prior Year Period Second Quarter Adjusted Diluted EPS of $2.04, up 7.9% Versus Prior Year Period Raised 2017 Guidance Range for GAAP Revenue Growth from a...

Wednesday 2nd August 2017

Dynavax Provides U.S. Regulatory Update on HEPLISAV-B(TM) Following FDA Advisory Committee Meeting

BERKELEY, CA--(Marketwired - August 03, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration (FDA) has requested more detailed information about the company's proposed post-marketing study for HEPLISAV-B™ [Hepatitis B Vaccine, Recombinant (Adjuvanted)] based on feedback received from the FDA's Vaccines and Related Biological Products ...

Tuesday 1st August 2017

Dynavax Reports Second Quarter 2017 Financial Results

BERKELEY, CA--(Marketwired - August 02, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today reported financial results for the second quarter ended June 30, 2017. Cash, cash equivalents and marketable securities were $127.0 million at June 30, 2017 compared to $81.4 million at December 31, 2016. The increase was primarily due to net proceeds of $88.2 million during the first half of 201...

Monday 31st July 2017

Mincom Provides Update on Proposed Transaction

OTTAWA, ONTARIO -- (Marketwired) -- 08/01/17 -- Mincom Capital Corporation ("Mincom" or the "Corporation") (TSX VENTURE: MOI) is pleased to provide the following update with respect to a transaction to purchase all of issued and outstanding shares of Braille Holdings Inc. held by Grafoid Inc. (the "Proposed Transaction"). The Proposed Transaction was previously announced on October 18, 2016 and ...

Thursday 27th July 2017

Dynavax Announces FDA Advisory Committee Vote in Favor of HEPLISAV-B(TM)

BERKELEY, CA--(Marketwired - July 28, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 12 to 1 that the safety data for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] support licensure for immunization against hepatitis B infection in adu...

Cheese Market by Source Cow Milk, Sheep Milk, Goat Milk, and Buffalo Milk, Type Natural Cheese and Processed Cheese, Product Mozzarella, Cheddar, Feta, Parmesan, Roquefort, and Others, and Distribution Channel Hypermarkets, Supermarkets, Food Specialty St

Cheese is one of the most consumed food products, owing to its high nutritious value along with presence of necessary vitamins, proteins, and other nutrients. It is a rich source of calcium that helps to maintain strong teeth and increases bone strength. Further, cheese contains linoleic acid and sphingolipids, which helps to prevent cancer. Moreover, vitamin B present in cheese can reduce blood p...

Monday 24th July 2017

Tauriga Sciences, Inc. and Ice + Jam LLC Prepare for Autumn 2017 Commercial Product Launch with Commencement of Laboratory Work to Reformulate Cupuacu Butter Lip Balm Product Texture

NEW YORK, NY -- (Marketwired) -- 07/25/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of life sciences businesses and technologies, today announced that, in cooperation with its licensor Ice + Jam LLC ("Ice + Jam"), it is working with New Jersey based Cosmetics R & D Laboratory, Ariel Laboratories ("Ariel Labs"), to reformulate its propriet...

Monday 10th July 2017

Helix BioPharma Corp. Announces Collaboration with Moffitt Cancer Center

TORONTO, ONTARIO -- (Marketwired) -- 07/11/17 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered into a collaboration agreement with Moffitt Cancer Center to extract radiomics data using their proprietary HealthMyne platform...

Sunday 9th July 2017

Nephros Provides Corporate Update and Second Quarter 2017 Revenue Guidance

RIVER EDGE, NJ -- (Marketwired) -- 07/10/17 -- Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), is providing a general update ...

Wednesday 5th July 2017

Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform

Licensing agreements with all patent holders have been completed Enables Horizon to use gene editing directly as a therapeutic New technology has immediate applications in biomanufacturing, diagnostics, cell and gene therapy Cambridge, UK, 05 July 2017: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or “the Company”), the world leader in the application...


Quick Search
Advertisement
 

News Quicklinks